Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 1014
Aptamer sequence: GCCUUUUCGGGAUACGCGGAGGGUGGGCAA
Target unique ID: Other-34
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_924 TAFapt1 Other leukemic AML1-MTG8 fusion protein 3.61 nM 20 mM sodium phosphate (pH 6.5), 2 mM magnesium acetate, 200 mM potassium acetate, 5% glycerol, 0.05% Triton X-100, 5 mM b-mercaptoethanol 32870501
Structure information of aptamer
Aptamer Sequence: GCCUUUUCGGGAUACGCGGAGGGUGGGCAA
The optimal secondary structure in dot-bracket notation: (((((((((.......)))))...))))..
The centroid secondary structure in dot-bracket notation: (((((((((.......)))))...))))..
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_924 Description TAFapt1
Aptamer chemistry RNA Length 30 nt
GC content 63.3% Molecular weight 9,739.82 Da
Molarity of 1 μg/μl solution 102.67 μM Number of G-quadruplexes 2
G-Score 18 Function Targeted therapy
Sequence GCCUUUUCGGGAUACGCGGAGGGUGGGCAA
Applications The aptamer could bind to the AML1-MTG8 fusion protein and dissociate the AML1-MTG8/DNA complex, suggesting that it can inhibit the dominant negative effects of AML1-MTG8 against normal AML1 function and serve as a potential therapeutic agent for leukemia
Target information
Type Detail Type Detail
Target ID Other-34 Name leukemic AML1-MTG8 fusion protein
Activity data

No relevant experimental diagram

Interaction ID 1014
Target type Other
Target unique ID Other-34
Activity 3.61 nM
Binding Conditions/Buffer

20 mM sodium phosphate (pH 6.5), 2 mM magnesium acetate, 200 mM potassium acetate, 5% glycerol, 0.05% Triton X-100, 5 mM b-mercaptoethanol

Assay

N/A

PubMed ID 32870501
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_377 RNA CUUCGGGAUUUGAGGGUAGAAUGGGACUA 56.67%
Apta_319 RNA ACCCUGAUGGUAGACGCCGGGGUG 53.33%
Apta_855 RNA UCACUGUUAUCCGAUAGCAGCGCGGGAUGA 53.33%
Apta_243 RNA GCUUGAAGCUAGCAGUAAGACUAGCGCUACGGAUGGGUGUGCG 51.16%
Apta_218 RNA AGCCGCGAGGGGAGGGAUAGGGUAGGGCGCGGCU 50.00%
Apta_231 RNA GGGAGGACGAUGCGGGUGUGGGGCG 50.00%
Apta_630 DNA GACCAGGGCAAACGGTAGGGAGTGGTC 50.00%
Apta_488 DNA CGACCAGGGTGGGAGGGGGACGGGCTGGCGGCGCGCGGTAATG 48.84%
Apta_47 DNA GACCTAGCAGTGGACATGTGGCAGGGTGAAGTGGCATCGTC 48.78%
Apta_402 RNA GCCUGUAAGGUGGUCGGUGUGGCGAGUGUGUUAGGAGAGAUUGC 47.73%
Apta_365 RNA GGACCUAUGCAGUAGCCAGUGUGGACUGGGCUGCCCCCCC 47.50%
Apta_521 RNA GGGUUGGGAAGAAACUGUGGCACUUCGGUGCCAGCAACCC 47.50%
Apta_831 DNA CCGCCCAGCGGGGGTAGGGCCGGACGTAGGAGGAGCTGCG 47.50%
Apta_880 DNA GCCGCACAATCGGGTTGGGCAGGGAGGGCACGTGTGGCGC 47.50%
Apta_1190 DNA TTCAGGGCGGGGTAAACGGGAGGTGGGGGGGGCTTGGGAC 47.50%
Apta_848 RNA CACCACGAUCACGGUUUCCCUCGCAGGUAAGGUGUAGA 47.37%
Apta_1142 RNA ACGAGUCACACGUUGAUGACUGGAUGGUAGUUAAAGAGGGUGGGGCAACAA 47.06%
Apta_634 RNA GGUCUUACGUCGUUCGCGACUAUUGGGAGACC 46.88%
Apta_381 RNA AUUCUGUUGGCGAACUGUACGCAAGUACUGGAUGACAGCCUAUCUAU 46.81%
Apta_27 DNA AGGGGGAGGGGTGGGGCCGGGCAGA 46.67%